Safe and Effective Drug Act - Requires the Director of the National Institutes of Health (NIH), acting through the Director of the National Institute on Drug Abuse, to develop a meta-analysis and report to Congress on the scientific data regarding the safety and health risks of smoking marijuana and the clinically-proven effectiveness of smoking marijuana for medicinal purposes. Requires the Commissioner of Food and Drugs to: (1) post such report on the Internet site of the Food and Drug Administration not later than 30 days after receipt; and (2) promptly disseminate such report to principal public health agencies of all States, and to public health associations, health care professionals, and other appropriate entities that advocate or recommend the smoking of marijuana by patients for medicinal purposes.
[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5429 Introduced in House (IH)]
108th CONGRESS
2d Session
H. R. 5429
To require the National Institute on Drug Abuse to develop a meta-
analysis of the available scientific data regarding the safety and
health risks of smoking marijuana and the clinically-proven
effectiveness of smoking marijuana for medicinal purposes, and to
require the Food and Drug Administration to promptly disseminate the
meta-analysis.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
December 6, 2004
Mr. Souder (for himself, Mr. Kingston, Mr. Sessions, Mr. Smith of New
Jersey, and Mr. Bonilla) introduced the following bill; which was
referred to the Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To require the National Institute on Drug Abuse to develop a meta-
analysis of the available scientific data regarding the safety and
health risks of smoking marijuana and the clinically-proven
effectiveness of smoking marijuana for medicinal purposes, and to
require the Food and Drug Administration to promptly disseminate the
meta-analysis.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Safe and Effective Drug Act''.
SEC. 2. SAFETY AND EFFECTIVENESS OF SMOKING MARIJUANA FOR MEDICINAL
PURPOSES; META-ANALYSIS BY NATIONAL INSTITUTE ON DRUG
ABUSE.
(a) In General.--The Director of the National Institutes of Health,
acting through the Director of the National Institute on Drug Abuse
(referred to in this Act as the ``Director of the Institute''), shall
develop a meta-analysis of the available scientific data regarding the
safety and health risks of smoking marijuana and the clinically-proven
effectiveness of smoking marijuana for medicinal purposes.
(b) Completion of Meta-Analysis; Report.--Not later than 120 days
after the date of the enactment of this Act, the Director of the
Institute shall complete the meta-analysis under subsection (a) and
submit to the Congress a report providing the meta-analysis. The
Director shall transmit a copy of the report to the Commissioner of
Food and Drugs.
SEC. 3. DISSEMINATION OF META-ANALYSIS BY FOOD AND DRUG ADMINISTRATION.
(a) Public Access to Meta-Analysis Through Internet.--Not later
than 30 days after receiving from the Director of the Institute the
report under section 2(b), the Commissioner of Food and Drugs shall
post such report on the Internet site of the Food and Drug
Administration.
(b) Dissemination of Meta-Analysis to Certain Public Health
Agencies and Other Appropriate Entities.--Promptly after receiving from
the Director of the Institute the report under section 2(b), the
Commissioner of Food and Drugs shall disseminate the report--
(1) to principal public health agencies of all States,
including those that authorize the smoking of marijuana for
medicinal purposes; and
(2) to public health associations, health care
professionals, and other appropriate entities that advocate or
recommend the smoking of marijuana by patients for medicinal
purposes.
(c) Definition.--As used in this section, the term ``State'' means
each of the several States, the District of Columbia, the Commonwealth
of Puerto Rico, the Commonwealth of the Northern Mariana Islands,
American Samoa, Guam, the Virgin Islands, and any other territory or
possession of the United States.
<all>
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line